178 related articles for article (PubMed ID: 26690494)
1. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.
Imai H; Kaira K; Mori K; Ono A; Akamatsu H; Matsumoto S; Taira T; Kenmotsu H; Harada H; Naito T; Murakami H; Endo M; Nakajima T; Yamada M; Takahashi T
BMC Cancer; 2015 Dec; 15():989. PubMed ID: 26690494
[TBL] [Abstract][Full Text] [Related]
2. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
Inal A; Kaplan MA; Kucukoner M; Urakcı Z; Kılınc F; Isıkdogan A
Rev Port Pneumol; 2014; 20(2):62-8. PubMed ID: 24210228
[TBL] [Abstract][Full Text] [Related]
3. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
4. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
5. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer?
Inal A; Kaplan MA; Kucukoner M; Urakci Z; Karakus A; Nas N; Guven M; Isikdogan A
Asian Pac J Cancer Prev; 2012; 13(4):1491-4. PubMed ID: 22799354
[TBL] [Abstract][Full Text] [Related]
6. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
8. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino M; Rullan AJ; Saigí M; Peiró I; Montanya E; Palmero R; Ruffinelli JC; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Cardenal F; Nadal E
BMC Cancer; 2019 Feb; 19(1):165. PubMed ID: 30791870
[TBL] [Abstract][Full Text] [Related]
9. Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab.
Taniguchi Y; Tamiya A; Isa SI; Nakahama K; Okishio K; Shiroyama T; Suzuki H; Inoue T; Tamiya M; Hirashima T; Imamura F; Atagi S
Anticancer Res; 2017 Oct; 37(10):5857-5862. PubMed ID: 28982912
[TBL] [Abstract][Full Text] [Related]
10. Elevated lactic acid is a negative prognostic factor in metastatic lung cancer.
Vlachostergios PJ; Oikonomou KG; Gibilaro E; Apergis G
Cancer Biomark; 2015; 15(6):725-34. PubMed ID: 26406401
[TBL] [Abstract][Full Text] [Related]
11. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
Koh YW; Lee HW
Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
[TBL] [Abstract][Full Text] [Related]
13. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
Liang Y; Wang L; Zhu Y; Lin Y; Liu H; Rao H; Xu G; Rong T
Cancer; 2012 Oct; 118(19):4748-58. PubMed ID: 22359203
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer.
Baykara M; Yaman M; Buyukberber S; Tufan G; Demirci U; Benekli M; Coskun U; Ozet A; Umit Bagriacik E
J BUON; 2013; 18(4):921-7. PubMed ID: 24344018
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution.
Inal A; Kaplan MA; Kucukoner M; Karakus A; Isikdogan A
J BUON; 2012; 17(3):533-6. PubMed ID: 23033295
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
Koh YW; Lee SJ; Park SY
Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
[TBL] [Abstract][Full Text] [Related]
17. Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients.
Cao S; Jin S; Shen J; Cao J; Zhang H; Meng Q; Wang C; Zhang A; Zhang P; Yu Y
Oncotarget; 2017 Jan; 8(5):8657-8669. PubMed ID: 28055965
[TBL] [Abstract][Full Text] [Related]
18. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
19. The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy.
Jiang AG; Lu HY
J Chemother; 2015 Feb; 27(1):35-9. PubMed ID: 24716851
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
[No Abstract] [Full Text] [Related]
[Next] [New Search]